Overview
Chengda Ren practices in Zhabei, China. Ren is rated as an Advanced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Their top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinitis Pigmentosa, and Retinopathy Pigmentary Mental Retardation.
Their clinical research consists of co-authoring 26 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 9 articles in the study of Age-Related Macular Degeneration (ARMD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Late-Onset Retinal Degeneration
- Experienced
- Dry Eye SyndromeRen isExperienced. Learn about Dry Eye Syndrome.
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Retinitis PigmentosaRen isExperienced. Learn about Retinitis Pigmentosa.
- Retinopathy Pigmentary Mental Retardation
- RhabdomyosarcomaRen isExperienced. Learn about Rhabdomyosarcoma.